9989:HKEXShenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Analysis

Sundrug Co.,Ltd. is trading at 3,984 JPY, notably below its 20‑day SMA of 4,091 JPY and the 50‑day SMA of 4,161 JPY, signaling a bearish technical backdrop. The RSI sits at 39, hinting at near‑oversold conditions, while the MACD histogram remains negative, reinforcing the downtrend. Support is identified around 3,889 JPY and resistance near 4,310 JPY, with volume trending upward despite a current volume that lags its 10‑day average.
Fundamentally, the stock appears undervalued with a trailing PE of 14.7 versus an industry average of 26.4, and it offers an attractive 3.35% dividend yield supported by a 48% payout ratio. However, the company carries a high debt‑to‑equity ratio of 17.6, and both operating and free cash flow are reported as zero, raising concerns about cash generation. Volatility stands at 18% over the past month, beta is exceptionally low at 0.018, and the market sentiment index reads “Extreme Greed” at 81, suggesting a potential disconnect between price action and broader market optimism.